JACC. Case reports · 2026
Dedicated Transcatheter Valve for Pure Aortic Regurgitation in a Failed Stentless Bioprosthesis.
Клинический случайСтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Corona Silvia, Mrad Sebastián, Kouz Remi, Ibrahim Reda, Julien Marco, Ibrahim Marina, Henri Christine, David Louis-Philippe, von Bardeleben Ralph Stephan, Ben Ali Walid
Аннотация
BACKGROUND: An 80-year-old man presented with progressive dyspnea due to severe isolated regurgitation of a 29-mm ATS 3f stentless (model 1000) aortic bioprosthesis. Because of his advanced age and multiple severe comorbidities, the Heart Team opted for a valve-in-valve transcatheter aortic valve replacement (TAVR).
CASE SUMMARY: Based on preprocedural computed tomography planning, a valve-in-valve TAVR procedure was successfully performed via transfemoral access using a 27-mm JenaValve Trilogy System.
DISCUSSION: Although the use of dedicated TAVR devices for the treatment of native aortic regurgitation has been well-described, to our knowledge, there are no existing reports on their use to address regurgitation caused by the structural valve deterioration of a stentless bioprosthesis.
TAKE-HOME MESSAGE: Consider a dedicated transcatheter valve to treat pure regurgitation in a failing stentless bioprosthesis.
CASE SUMMARY: Based on preprocedural computed tomography planning, a valve-in-valve TAVR procedure was successfully performed via transfemoral access using a 27-mm JenaValve Trilogy System.
DISCUSSION: Although the use of dedicated TAVR devices for the treatment of native aortic regurgitation has been well-described, to our knowledge, there are no existing reports on their use to address regurgitation caused by the structural valve deterioration of a stentless bioprosthesis.
TAKE-HOME MESSAGE: Consider a dedicated transcatheter valve to treat pure regurgitation in a failing stentless bioprosthesis.